➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Moodys
Medtronic
AstraZeneca
Dow

Last Updated: February 27, 2021

DrugPatentWatch Database Preview

Carboplatin - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for carboplatin and what is the scope of patent protection?

Carboplatin is the generic ingredient in two branded drugs marketed by Cipla Ltd, Eugia Pharma, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, Pliva, Sandoz, Watson Labs Teva, West-ward Pharms Int, Corden Pharma, Accord Hlthcare, Actavis Totowa, Akorn, Gland Pharma Ltd, Meitheal, Mylan Institutional, Novast Labs, Pharmachemie Bv, Pliva Lachema, Sandoz Inc, Sun Pharm, Teva Parenteral, Teva Pharms Usa, and Cordenpharma, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for carboplatin. Eight suppliers are listed for this compound.

Drug Prices for carboplatin

See drug prices for carboplatin

Recent Clinical Trials for carboplatin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Andrew J. Armstrong, MDPhase 2
IpsenPhase 2
Stanford UniversityPhase 3

See all carboplatin clinical trials

Pharmacology for carboplatin
Medical Subject Heading (MeSH) Categories for carboplatin
Paragraph IV (Patent) Challenges for CARBOPLATIN
Tradename Dosage Ingredient NDA Submissiondate
PARAPLATIN INJECTABLE;INJECTION carboplatin 019880
PARAPLATIN INJECTABLE;INTRAVENOUS carboplatin 020452

US Patents and Regulatory Information for carboplatin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmachemie Bv CARBOPLATIN carboplatin INJECTABLE;INTRAVENOUS 077269-002 Oct 14, 2004 AP RX No Yes   Start Trial   Start Trial   Start Trial
Akorn CARBOPLATIN carboplatin INJECTABLE;INTRAVENOUS 091268-002 Jul 28, 2010 AP RX No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa CARBOPLATIN carboplatin INJECTABLE;INTRAVENOUS 077432-001 Sep 29, 2006 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira CARBOPLATIN carboplatin INJECTABLE;INTRAVENOUS 076517-002 Oct 14, 2004 AP RX No No   Start Trial   Start Trial   Start Trial
Mylan Institutional CARBOPLATIN carboplatin INJECTABLE;INTRAVENOUS 077998-002 Apr 24, 2007 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for carboplatin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-001 Mar 3, 1989   Start Trial   Start Trial
Cordenpharma PARAPLATIN carboplatin INJECTABLE;INTRAVENOUS 020452-001 Jul 14, 2003   Start Trial   Start Trial
Cordenpharma PARAPLATIN carboplatin INJECTABLE;INTRAVENOUS 020452-002 Jul 14, 2003   Start Trial   Start Trial
Cordenpharma PARAPLATIN carboplatin INJECTABLE;INTRAVENOUS 020452-004 Jan 15, 2004   Start Trial   Start Trial
Cordenpharma PARAPLATIN carboplatin INJECTABLE;INTRAVENOUS 020452-003 Jul 14, 2003   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Dow
Baxter
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.